25.80
+4.67%
Close of 9 Nov 2026, in TWD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Shangya Technology Co
Its shares trade on Taipei Exchange under the ticker 6130.TWO. It has been listed since 2 January 2002. In the fiscal year to 31 December 2025, it reported revenue of TWD 154.7m and a net loss of TWD 76.3m. At that date it held total assets of TWD 877.8m and shareholders' equity of TWD 545.5m.
Xingbao International Co., Ltd. engages in the development of biomedical products. The company is headquartered in Taipei City, Taipei. The company went IPO on 2002-01-02. The businesses include Western medicine trading, solar power generation, real estate leasing, and power integrated circuit (IC) design, production, and sales. The company sells products directly or through distributors to medical centers, public hospitals, foundation hospitals and clinics, pharmacies. The company sells power to Taiwan power companies. The sales targets also include company line numbers and individuals. Products include nervous system drugs, antineoplastic drugs, hypoglycemic drugs, cardiovascular system drugs, respiratory drugs, sexual dysfunction drugs, non-infectious pain relievers and anti-inflammatory drugs and hepatitis drugs. Solar energy is used for electricity supply. Power ICs are used in mobile phones, tablet charging chips, Type C expansion houses, industrial control equipment, televisions, personal computers and notebook computers, automobiles and smart fan control.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 2 Jan 2002
- Employees
- 457
- Website
- singbao.com ↗
Leadership
Pay as last reported
- Mr. Kun-Jian HuangChairman of the Board, General Manager
- Xiaoling HuangChief Financial Officer, since 2017
- Liping GuoCorporate Governance Officer
- Xiang'en WuChief Information Security Officer
- Tengting HuangDirector
- Yucheng SuDirector
- Youquan ZengDirector, since 2015
- Cuiting KeIndependent Director
- Mr. Yibin LinIndependent Director
- Huangqing WuIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Shangya Technology develops biomedical products for medical centers and hospitals in Taipei City.
- Xingbao International sells power ICs used in mobile phones and industrial control equipment.
- The company's solar power generation supports electricity supply in Taiwan.
Weaknesses
- Xingbao International's Western medicine trading targets company line numbers and individuals.
- The company's real estate leasing business is limited to Taipei City.
- Shangya Technology's sales focus on medical centers and public hospitals.
Opportunities
- Xingbao International can expand power IC sales to automotive and smart fan control markets.
- Shangya Technology can leverage solar energy for broader electricity supply in Taiwan.
- The company's biomedical products target nervous system and cardiovascular drugs in growing markets.
Threats
- Xingbao International's power IC design faces competition from other manufacturers.
- The company's solar power generation may face regulatory changes in Taiwan.
- Shangya Technology's medical product sales are dependent on hospital contracts.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.